AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OncoCyte Corporation (OCX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.14

-0.01 (-0.47%)

At close: Jan 15, 2025, 10:52 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	1.50M	958.00K	7.73M	1.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.09M	976.00K	7.54M	1.85M	344.00K	559.00K	580.00K	387.00K	283.00K	n/a	n/a
Gross Profit	413.00K	-18.00K	188.00K	-639.00K	-344.00K	-559.00K	-580.00K	-387.00K	-283.00K	n/a	n/a
Operating Income	-25.14M	-18.00M	-46.95M	-29.71M	-22.24M	-15.20M	-18.85M	-11.14M	-8.72M	-4.97M	-3.50M
Interest Income	n/a	77.00K	209.00K	252.00K	299.00K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-24.86M	-18.61M	-73.36M	-31.19M	-22.43M	-15.75M	-19.38M	-11.17M	-8.73M	-4.99M	-3.50M
Net Income	-27.78M	-73.44M	-64.10M	-29.93M	-22.33M	-15.75M	-19.38M	-11.17M	-8.73M	-4.99M	-3.50M
Selling & General & Admin	13.54M	23.01M	33.50M	23.28M	15.45M	8.69M	11.68M	5.46M	4.19M	1.01M	552.00K
Research & Development	9.29M	7.30M	13.63M	9.80M	6.79M	6.51M	7.17M	5.68M	4.53M	3.96M	2.94M
Other Expenses	2.72M	-67.00K	-37.00K	27.00K	-3.00K	91.00K	n/a	n/a	2.00K	-11.00K	n/a
Operating Expenses	25.64M	30.31M	47.13M	33.08M	22.24M	15.20M	18.85M	11.14M	8.72M	4.97M	3.50M
Interest Expense	52.00K	77.00K	209.00K	252.00K	299.00K	216.00K	217.00K	28.00K	19.00K	2.00K	n/a
Selling & Marketing Expenses	2.79M	1.13M	11.17M	6.49M	2.16M	1.68M	2.44M	1.20M	324.00K	n/a	n/a
Cost & Expenses	26.64M	31.29M	54.67M	34.94M	22.24M	15.20M	18.85M	11.14M	8.72M	4.97M	3.50M
Income Tax	n/a	54.83M	-9.26M	-1.25M	-97.00K	-336.00K	217.00K	-387.00K	-262.00K	-9.00K	n/a
Shares Outstanding (Basic)	7.65M	5.54M	4.45M	3.27M	2.56M	1.89M	1.51M	1.33M	1.05M	324.62K	324.62K
Shares Outstanding (Diluted)	7.65M	5.54M	4.45M	3.27M	2.56M	1.89M	1.51M	1.33M	1.05M	324.62K	324.62K
EPS (Basic)	-3.75	-13.26	-14.42	-9.14	-8.71	-8.32	-12.83	-8.42	-8.32	-15.36	-10.77
EPS (Diluted)	-3.75	-13.26	-14.42	-9.14	-8.71	-8.32	-12.83	-8.42	-8.32	-15.36	-10.77
EBITDA	-23.12M	-13.31M	-48.46M	-30.54M	-21.89M	-15.20M	-18.27M	-11.14M	-8.44M	-4.69M	-3.22M
Depreciation & Amortization	1.68M	5.22M	4.21M	394.00K	344.00K	559.00K	580.00K	387.00K	283.00K	281.00K	277.00K